Beckman Daniella

CIK 00015134227 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001513422

Recent Transactions

50 trades

Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2026-02-03$12.26/sh−10,204→ 184,410 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2026-02-03$12.90/sh−113→ 184,297 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2026-02-02+265,980→ 265,980 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2026-02-02+44,330→ 194,614 total
Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−10,842→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−4,570→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−3,902→ 10,842 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−7,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,300→ 0 total
Award
Blueprint Medicines Corp
Common Stock
2025-06-18$128.12/sh+3,902→ 14,744 total
Award
Upstream Bio, Inc.$UPB
Stock Option (Right to Buy)
2025-06-10+17,096→ 17,096 total
Award
Vor Biopharma Inc.$VOR
Stock Option (Right to Buy)
2025-05-22+30,000→ 30,000 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2025-02-05$3.16/sh−3,948→ 150,284 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2025-02-04$2.99/sh−4,284→ 154,232 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2025-02-03+26,119→ 158,516 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2025-02-03+156,713→ 156,713 total
Award
Upstream Bio, Inc.$UPB
Stock Option (Right to Buy)
2024-10-10+34,681→ 34,681 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-06-12+4,570→ 4,570 total
Award
Blueprint Medicines Corp
Common Stock
2024-06-12+2,242→ 10,842 total
Award
Vor Biopharma Inc.$VOR
Stock Option (Right to Buy)
2024-05-23+30,000→ 30,000 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2024-02-07$12.62/sh−1,817→ 132,397 total
Sale
Tango Therapeutics, Inc.$TNGX
Common Stock
2024-02-06$12.56/sh−1,908→ 134,214 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2024-02-01+39,413→ 39,413 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2024-02-01+236,475→ 236,475 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-06-21+5,300→ 5,300 total
Award
Blueprint Medicines Corp
Common Stock
2023-06-21+2,600→ 8,600 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2023-05-26+30,000→ 30,000 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2023-03-01+197,051→ 197,051 total
Award
Tango Therapeutics, Inc.$TNGX
Common Stock
2023-03-01+32,842→ 96,709 total
Award
Blueprint Medicines Corp
Common Stock
2022-06-21+2,600→ 6,000 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-06-21+5,300→ 5,300 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2022-06-14+16,911→ 16,911 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2022-02-01+150,000→ 150,000 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-12-08+7,000→ 7,000 total
Award
Blueprint Medicines Corp
Common Stock
2021-12-08+3,400→ 3,400 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−18,900→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−67,995→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−18,900→ 0 total
Sale
Translate Bio, Inc.
Stock Option (right to buy)
2021-09-14−20,000→ 0 total
Award
Tango Therapeutics, Inc.$TNGX
Stock Option (Right to Buy)
2021-08-12+380,485→ 380,485 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2021-06-16+20,000→ 20,000 total
Award
Vor Biopharma Inc.$VOR
Stock Option (right to buy)
2021-02-05+16,900→ 16,900 total
Other
5:01 Acquisition Corp.
Class B Common Stock
2020-10-16+30,000→ 30,000 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2020-06-16+18,900→ 18,900 total
Award
Translate Bio, Inc.
Stock Option (right to buy)
2019-06-18+18,900→ 18,900 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−100,000→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−6,000→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−100,000→ 0 total
Disposition to Issuer
IDENIX PHARMACEUTICALS INC
Stock Option (Right to Buy)
2014-08-05−100,000→ 0 total

Companies

Recent Filings

Address

C/O TANGO THERAPEUTICS, INC., 201 BROOKLINE AVE., SUITE 901

BOSTON, MA, 02215

View on SEC.gov